1. Home
  2. NBIX vs HLI Comparison

NBIX vs HLI Comparison

Compare NBIX & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$130.52

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

N/A

Current Price

$156.36

Market Cap

10.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
HLI
Founded
1992
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
10.6B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
NBIX
HLI
Price
$130.52
$156.36
Analyst Decision
Strong Buy
Buy
Analyst Count
22
7
Target Price
$180.91
$194.29
AVG Volume (30 Days)
1.1M
448.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
1.54%
EPS Growth
41.95
41.61
EPS
4.67
4.74
Revenue
$161,626,000.00
$2,389,416,000.00
Revenue This Year
$24.73
$13.77
Revenue Next Year
$13.14
$12.10
P/E Ratio
$27.99
$32.96
Revenue Growth
977.51
24.81
52 Week Low
$107.96
$134.41
52 Week High
$160.18
$211.78

Technical Indicators

Market Signals
Indicator
NBIX
HLI
Relative Strength Index (RSI) 51.13 51.80
Support Level $124.62 $135.21
Resistance Level $135.88 $164.25
Average True Range (ATR) 3.58 3.43
MACD -0.12 -0.06
Stochastic Oscillator 59.98 36.29

Price Performance

Historical Comparison
NBIX
HLI

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: